Trial Design Solutions

  1. Overcome Biosafety Challenges With An Innovative IBC 3/5/2026

    Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.

  2. Home Trial Support: The Engine Powering DCT 8/10/2021

    By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.

  3. Selecting The Right Pain Model For Early Phase Analgesic Trials 1/26/2023

    Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.

  4. Medical Writing: A Collaborative Approach 7/31/2024

    Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.

  5. Greenphire Patient Payments 10/24/2025

    esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.

  6. Even The Most Complex Studies Reach Milestones Faster 8/28/2023

    Whether it's complex randomization, adaptive trials, Direct-to-Patient models, or recurring visit cycles, discover how Rave RTSM is able to grant your team instant access to the full spectrum of current and forthcoming study features.

  7. A New Blueprint For Transforming Feasibility And Recruitment 10/20/2025

    Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.

  8. Unlocking The Power Of Patient Recruitment For Clinical Trials 3/13/2026

    Accelerate clinical trial timelines and reduce site burden through direct-to-patient digital recruitment and real-time screening insights across 120+ therapeutic areas globally.

  9. Safe-To-Site Initiative 12/8/2025

    By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.

  10. Rave RTSM: Direct-To-Patient 10/3/2022

    As the healthcare industry continues to deepen its focus on virtual trials and patient-centricity, the popularity of Direct-to-Patient (DtP) services in the clinical trial setting has grown significantly. Rave RTSM DtP (Randomization and Trial Supply Management Direct to Patient) brings investigational medicinal products (IMP) directly to a patient’s home, bypassing the need for the patient to travel directly to a site.